Nanajian, A.; Scott, M.; Burcus, N.I.; Ruedlinger, B.L.; Oshin, E.A.; Beebe, S.J.; Guo, S.
Nano-Pulse Treatment Overcomes the Immunosuppressive Tumor Microenvironment to Elicit In Situ Vaccination Protection against Breast Cancer. Vaccines 2024, 12, 633.
https://doi.org/10.3390/vaccines12060633
AMA Style
Nanajian A, Scott M, Burcus NI, Ruedlinger BL, Oshin EA, Beebe SJ, Guo S.
Nano-Pulse Treatment Overcomes the Immunosuppressive Tumor Microenvironment to Elicit In Situ Vaccination Protection against Breast Cancer. Vaccines. 2024; 12(6):633.
https://doi.org/10.3390/vaccines12060633
Chicago/Turabian Style
Nanajian, Anthony, Megan Scott, Niculina I. Burcus, Brittney L. Ruedlinger, Edwin A. Oshin, Stephen J. Beebe, and Siqi Guo.
2024. "Nano-Pulse Treatment Overcomes the Immunosuppressive Tumor Microenvironment to Elicit In Situ Vaccination Protection against Breast Cancer" Vaccines 12, no. 6: 633.
https://doi.org/10.3390/vaccines12060633
APA Style
Nanajian, A., Scott, M., Burcus, N. I., Ruedlinger, B. L., Oshin, E. A., Beebe, S. J., & Guo, S.
(2024). Nano-Pulse Treatment Overcomes the Immunosuppressive Tumor Microenvironment to Elicit In Situ Vaccination Protection against Breast Cancer. Vaccines, 12(6), 633.
https://doi.org/10.3390/vaccines12060633
